SCHEMBL434918

SCHEMBL434918

C[C@H](N)C(=O)C[C@H](N)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.58
SLC1A3 P43003 5/20 0.52
SLC1A2 P43004 5/20 0.52
SLC1A1 P43005 4/20 0.52
GRIK1 P39086 11/20 0.50
GRIK2 Q13002 5/20 0.50
GRIA4 P48058 3/20 0.50
GRIK3 Q13003 3/20 0.50
GRIK5 Q16478 3/20 0.50
GRIA2 P42262 2/20 0.50
GRIA1 P42261 1/20 0.50
GRM1 Q13255 1/20 0.48
GRM2 Q14416 1/20 0.48
LTA4H P09960 1/20 0.45
PTGS1 P23219 1/20 0.44
SLC7A11 Q9UPY5 1/20 0.44
GGT1 P19440 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380601 1.00 SLC7A5 (0.58) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL434919 1.00 SLC7A5 (0.58) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL21585639 1.00 SLC7A5 (0.58) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL21585654 0.98 SLC7A5 (0.56) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL21577845 0.85 SLC7A5 (0.58) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL21690060 0.85 SLC7A5 (0.58) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL10212363 0.85 SLC7A5 (0.58) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL21577850 0.81 SLC7A5 (0.54) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL18261645 0.81 SLC7A5 (0.54) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
Aspartic Acid SCHEMBL23454434 0.80 SLC7A5 (0.58) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750555-A NERVOUS SYSTEM DISORDERS; SKIN DISORDERS; IMMUNOLOGY GOEDECKE AKTIENGESELLSCHAFT (DE) 1998-05-12 US claimed
EP-1817109-B1 MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL MERCK PATENT GMBH (DE) 2020-02-26 EP disclosed
WO-2012012257-A2 BIVALENT MULTIFUNCTIONAL LIGANDS TARGETING Aβ OLIGOMERS AS TREATMENT FOR ALZHEIMER'S DISEASE VIRGINIA COMMONWEALTH UNIVERSITY (US) 2012-01-26 WO disclosed
US-7648636-B2 A chromatographic support including an immobilized ligand which combines an anion-exchange domain comprising an oligocyclic aza compound with endocyclic nitrogen and a non-ionic, second binding domain to allow adjustment of the overall hydrophobicity/hydrophilicity; separation; purification; peptides MERCK PATENT GMBH (DE) 2010-01-19 US disclosed
EP-2119372-A1 Aroma compositions and preparations containing N-alpha-beta-alanyl-dipeptides Symrise GmbH & Co. KG (DE) 2009-11-18 EP disclosed
US-20090104633-A1 Kit for Highly Sensitive Detection Assays VYZKUMNY USTAV VETERINARNIHO LEKARSTVI (CZ) 2009-04-23 US disclosed
EP-1971864-A2 KIT COMPRISING 2,4-DICHLOROPHENOXYACETIC ACD DERIVATIVES AND ANTIBODIES FOR HIGHLY SENSITIVE DETECTION ASSAYS Forschungszentrum Borstel (DE) 2008-09-24 EP disclosed
US-20080164211-A1 Mixed-Modal Anion-Exchanged Type Separation Material MERCK PATENT GMBH (DE) 2008-07-10 US disclosed
EP-1817109-A1 MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL Merck Patent GmbH (DE) 2007-08-15 EP disclosed
WO-2007051603-A2 KIT COMPRISING 2, 4- DICHLOROPHENOXYACETIC ACD DERIVATIVES AND ANTIBODIES FOR HIGHLY SENSITIVE DETECTION ASSAYS FORSCHUNGSZENTRUM BORSTEL (DE) 2007-05-10 WO disclosed
EP-1693108-A1 Mixed-modal anion-exchange type separation material MERCK PATENT GmbH (DE) 2006-08-23 EP disclosed
WO-2006058623-A1 MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL MERCK PATENT GMBH (DE) 2006-06-08 WO disclosed
US-5750555-A NERVOUS SYSTEM DISORDERS; SKIN DISORDERS; IMMUNOLOGY GOEDECKE AKTIENGESELLSCHAFT (DE) 1998-05-12 US disclosed